Total raised
$1.5M
Last: SAFE 2025-10
Stage
Seed
Founded
2016
Headcount
14
HQ
—
Sector
Health Tech & Life Sciences
About
Ceretrieve has designed and developed CathTrap, a neurothrombectomy system with integrated embolic protection for ischemic stroke endovascular treatment. CathTrap provides physicians with a safe, easy-to-use device to prevent distal embolization during thrombectomy procedures for better treatment efficiency and improved clinical outcomes for patients. Ceretrieves aspiration catheter has an expandable soft tip that can enlarge its diameter from 6F to the clot size in order to provide a powerful aspiration force to extract and ingest the clot without compromising trackability in reaching the clot. Ceretrieve is a portfolio company of Trendlines.
Funding history · 2 rounds · $1.5M total
2025-10
SAFE
Undisclosed
2021-01
Seed
$1.5M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Ceretrieve's primary product?
- Ceretrieve's primary product is CathTrap, a neurothrombectomy system with integrated embolic protection designed for ischemic stroke endovascular treatment.
- What is the core functionality of Ceretrieve's CathTrap system?
- The CathTrap system is an aspiration catheter with an expandable soft tip that can enlarge its diameter from 6F to the clot size, providing powerful aspiration to extract and ingest clots while maintaining trackability.
- When was Ceretrieve founded?
- Ceretrieve was founded in December 2016.
- How many employees does Ceretrieve currently have?
- Ceretrieve currently has 14 employees.
- What was Ceretrieve's first recorded funding round?
- In January 2021, Ceretrieve completed a Seed round, raising a total of $1.5 million from investors including Israel Innovation Authority, The Trendlines Group, and Agriline.
- Which investor is Ceretrieve a portfolio company of?
- Ceretrieve is a portfolio company of The Trendlines Group.
- Who was appointed as Ceretrieve's Chairman in January 2021?
- Amir Belson was appointed as Ceretrieve's Chairman in January 2021, following a $1.5 million investment round.
- What is the most recent funding activity for Ceretrieve?
- Ceretrieve had a SAFE funding round in October 2025, with 4T Ventures as an investor.
- Who are the founders of Ceretrieve?
- The founders of Ceretrieve are Eytan Jaffe and Ronen Jaffe.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cathetersstrokeneurosurgerymedical-devicesischemiacardiology